Expertise in
5
conditions

Dr. Kim-hien T. Dao

Internal Medicine
OHSU Hospital
3181 SW Sam Jackson Park Rd, 
Portland, OR 
Accepting New Patients
Expertise in
5
conditions
OHSU Hospital
3181 SW Sam Jackson Park Rd, 
Portland, OR 

Overview

Kim-hien Dao is a primary care provider, practicing in Internal Medicine in Portland, Oregon.

Dr. Dao is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Chronic Myelomonocytic Leukemia (CMML), Philadelphia-Negative Chronic Myeloid Leukemia, Myelodysplastic Syndrome (MDS), Myeloproliferative Neoplasms (MPN), and Bone Marrow Aspiration.

She is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 3 clinical trials. Dr. Dao is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in OR

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

BridgeSpan
  • EPO
  • HMO
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Regence
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

OHSU Hospital
3181 SW Sam Jackson Park Rd, Portland, OR 97239

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The National Myelodysplastic Syndromes Natural History Study
The National Myelodysplastic Syndromes Natural History Study
Enrollment Status: Completed
Publish Date: February 03, 2026
Intervention Type: Other
A Phase 3, Randomized, Open-Label, Crossover Study of ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) Versus IV Decitabine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloid Leukemia (AML)
A Phase 3, Randomized, Open-Label, Crossover Study of ASTX727 (Cedazuridine and Decitabine Fixed-Dose Combination) Versus IV Decitabine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloid Leukemia (AML)
Enrollment Status: Completed
Publish Date: August 27, 2024
Intervention Type: Drug
Study Drugs: Cedazuridine, Decitabine
Study Phase: Phase 3
Prospective Evaluation of Ruxolitinib Efficacy for CNL/aCML Patients With Mutation of CSF3R
Prospective Evaluation of Ruxolitinib Efficacy for CNL/aCML Patients With Mutation of CSF3R
Enrollment Status: Completed
Publish Date: November 16, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

24 Total Publications

Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies.
Efficacy and safety of oral decitabine/cedazuridine in the chronic myelomonocytic leukaemia subpopulations from phase 2 and 3 studies.
Journal: British journal of haematology
Published: February 24, 2025
Similar Doctors
Expertise in
22
conditions
Dr. Kevin L. Winthrop
Internal Medicine
Expertise in
22
conditions
Dr. Kevin L. Winthrop
Internal Medicine
Before you request

OHSU Hospital

3181 SW Sam Jackson Park Rd, 
Portland, OR 
 (0.1 miles away)
503-494-4971
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kevin Winthrop is a primary care provider, practicing in Internal Medicine in Portland, Oregon. Dr. Winthrop is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Mycobacterium Avium Complex Infections, Shingles, Bronchiectasis, Cataract Removal, and Lung Transplant. Dr. Winthrop is currently accepting new patients.

Expertise in
5
conditions
Dr. Radko Komers
Internal Medicine
Expertise in
5
conditions
Dr. Radko Komers
Internal Medicine

OHSU Hospital

3181 SW Sam Jackson Park Rd, 
Portland, OR 
 (0.1 miles away)
503-494-8490
Languages Spoken:
English

Radko Komers is a primary care provider, practicing in Internal Medicine in Portland, Oregon. Dr. Komers is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Focal Segmental Glomerulosclerosis, Glomerulonephritis, IgA Nephropathy, and Alport Syndrome.

Expertise in
15
conditions
Dr. Salman Zahid
Internal Medicine
Expertise in
15
conditions
Dr. Salman Zahid
Internal Medicine

OHSU Hospital

3181 SW Sam Jackson Park Rd, 
Portland, OR 
 (0.1 miles away)
503-494-8211
Languages Spoken:
English
See accepted insurances

Salman Zahid is a primary care provider, practicing in Internal Medicine in Portland, Oregon. Dr. Zahid is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Peripartum Cardiomyopathy, Pulmonary Edema, Heart Block, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Frequently Asked Questions about Dr. Kim-hien T. Dao

How do I make an appointment with Dr. Kim-hien T. Dao?

You can book an appointment with Dr. Kim-hien T. Dao by calling their office at 503-494-5058. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kim-hien T. Dao a top-rated expert for Chronic Myelomonocytic Leukemia (CMML)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kim-hien T. Dao is classified as an Advanced expert for Chronic Myelomonocytic Leukemia (CMML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kim-hien T. Dao specialize in?

While Dr. Kim-hien T. Dao is a Internal Medicine, they have specific expertise in Chronic Myelomonocytic Leukemia (CMML), Philadelphia-Negative Chronic Myeloid Leukemia, and Myelodysplastic Syndrome (MDS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Kim-hien T. Dao participate in research or clinical trials?

Yes. Dr. Kim-hien T. Dao has published 24 articles and abstracts on conditions like Chronic Myelomonocytic Leukemia (CMML). You can view a list of Dr. Kim-hien T. Dao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kim-hien T. Dao accept my insurance?

Dr. Kim-hien T. Dao accepts most major insurance plans, including BridgeSpan and Moda Health. We recommend calling the office directly at 503-494-5058 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dao's expertise for a condition
ConditionClose
      View All 28 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile